Tae Won Kim

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 20

Top Topics

Patient Satisfaction

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Chinese journal of cancer

Experimental & molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Ji-Hye Oh, Sungyang Jo, Kye Won Park, Eun-Jae Lee, Seung Hyun Lee, Yun Su Hwang, Ha Ra Jeon, Yeonjin Ryu, Hee Jeong Yoon, Sung-Min Chun, Chong Jai Kim, Tae Won Kim, Chang Ohk Sung, Sehyun Chae, Sun Ju Chung
Whole-genome sequencing reveals an association between small genomic deletions and an increased risk of developing Parkinson's disease. Experimental & molecular medicine (2023)
Jayesh Desai, Guzman Alonso, Se Hyun Kim, Andres Cervantes, Thomas Benjamin Karasic, Laura Medina, Einat Shacham-Shmueli, Rasha Cosman, Alejandro Falcón Gonzalez, Eelke Gort, Tormod Kyrre Guren, Erminia Massarelli, Wilson H Miller, Luis Paz-Ares, Hans Prenen, Alessio Amatu, Chiara Cremolini, Tae Won Kim, Victor Moreno, Sai-Hong Ignatius Ou, Alessandro Passardi, Adrian Sacher, Armando Santoro, Rafal Stec, Susanna Ulahannan, Kathryn C Arbour, Patricia M LoRusso, Jia Luo, Manish R Patel, Yoonha Choi, Zhen Shi, Sandhya Mandlekar, Mark T Lin, Stephanie Royer-Joo, Julie Chang, Tomi Jun, Neekesh V Dharia, Jennifer L Schutzman, null null, Sae-Won Han
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial. Nature medicine (2023)
Lucia Taraborrelli, Yasin Şenbabaoğlu, Lifen Wang, Junghyun Lim, Kerrigan Blake, Noelyn Kljavin, Sarah Gierke, Alexis Scherl, James Ziai, Erin McNamara, Mark Owyong, Shilpa Rao, Aslihan Karabacak Calviello, Daniel Oreper, Suchit Jhunjhunwala, Guillem Argiles, Johanna Bendell, Tae Won Kim, Fortunato Ciardiello, Matthew J Wongchenko, Frederic J de Sauvage, Felipe de Sousa E Melo, Yibing Yan, Nathaniel R West, Aditya Murthy
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer. Nature communications 14 (1) (2023)
Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, Michael J Pishvaian, Yung-Jue Bang, Michael S Gordon, Ahmad Awada, D Ross Camidge, F Stephen Hodi, Grant A McArthur, Wilson H Miller, Andres Cervantes, Laura Q M Chow, Alexander M Lesokhin, Annemie Rutten, Mario Sznol, Deepali Rishipathak, Shang-Chiung Chen, Eric G Stefanich, Tony Pourmohamad, Maria Anderson, Jeong Kim, Mahrukh Huseni, Ina Rhee, Lillian L Siu
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Seung Tae Kim, Sun Young Kim, Jeeyun Lee, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Tae Won Kim, Yong Sang Hong, Seok Byung Lim, Ji Yeon Baek, Jae Hwan Oh, Joong Bae Ahn, Sang Joon Shin, Sae-Won Han, Seong Geun Kim, Seok Yun Kang, Sun Jin Sym, Dae Young Zang, Yeul Hong Kim, In Sil Choi, Jung Hun Kang, Min-Ji Kim, Young Suk Park
Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (33) (2022)
Tae Won Kim, Gilles Manceau, Ellen B Gurary, Nati Lerman, Karen Y Cui, Takayuki Yoshino
Olaparib with or without bevacizumab or bevacizumab and 5-fluorouracil in advanced colorectal cancer: Phase III LYNK-003. Future oncology (London, England) 17 (36) (2021)
Jeong Eun Kim, Jaeyong Choi, Chang-Ohk Sung, Yong Sang Hong, Sun Young Kim, Hyunjung Lee, Tae Won Kim, Jong-Il Kim
High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer. Experimental & molecular medicine 53 (3) (2021)
Ivana Yen, Frances Shanahan, Jeeyun Lee, Yong Sang Hong, Sang Joon Shin, Amanda R Moore, Jawahar Sudhamsu, Matthew T Chang, Inhwan Bae, Darlene Dela Cruz, Thomas Hunsaker, Christiaan Klijn, Nicholas P D Liau, Eva Lin, Scott E Martin, Zora Modrusan, Robert Piskol, Ehud Segal, Avinashnarayan Venkatanarayan, Xin Ye, Jianping Yin, Liangxuan Zhang, Jin-Soo Kim, Hyeong-Seok Lim, Kyu-Pyo Kim, Yu Jung Kim, Hye Sook Han, Soo Jung Lee, Seung Tae Kim, Minkyu Jung, Yoon-Hee Hong, Young Su Noh, Munjeong Choi, Oakpil Han, Malgorzata Nowicka, Shrividhya Srinivasan, Yibing Yan, Tae Won Kim, Shiva Malek
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma. Nature 594 (7863) (2021)
Yu-Rang Park, HaYeong Koo, Young-Kwang Yoon, Sumi Park, Young Suk Lim, Seunghee Baek, Hae-Reong Kim, Tae Won Kim
Expedited Safety Reporting to Sponsors Through the Implementation of an Alert System for Clinical Trial Management at an Academic Medical Center: Retrospective Design Study. JMIR medical informatics 8 (2) (2020)
Sinae Kim, YunJung Kim, YoungLan Hong, YunOk Kim, Joon Seo Lim, JiSung Lee, Tae Won Kim
Feasibility of a Hybrid Risk-Adapted Monitoring System in Investigator-Sponsored Trials in Cancer. Therapeutic innovation & regulatory science 55 (1) (2020)
Joon Seo Lim, Vanessa Topping, Ji Sung Lee, Keenan D Bailey, Sung-Han Kim, Tae Won Kim
Effects of providing manuscript editing through a combination of in-house and external editing services in an academic hospital. PloS one 14 (7) (2019)
Kyoungmin Lee, So Jung Lee, Shinkyo Yoon, Baek-Yeol Ryoo, Sang-We Kim, Sang Hyun Choi, Sang Min Lee, Eun Jin Chae, Yangsoon Park, Se-Jin Jang, Soo-Yeon Park, Young-Kwang Yoon, Seong Ho Park, Tae Won Kim
Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center. PloS one 14 (8) (2019)
Yu-Rang Park, Young Jo Yoon, HaYeong Koo, Soyoung Yoo, Chang-Min Choi, Sung-Ho Beck, Tae Won Kim
Utilization of a Clinical Trial Management System for the Whole Clinical Trial Process as an Integrated Database: System Development. Journal of medical Internet research 20 (4) (2018)
Kyung-Hee Lee, Tae Won Kim, Jung-Hun Kang, Jin-Soo Kim, Jin-Seok Ahn, Sun-Young Kim, Hwan-Jung Yun, Young-Jun Eum, Sung Ae Koh, Min Kyoung Kim, Yong Sang Hong, Jeong Eun Kim, Gyeong-Won Lee
Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial. Chinese journal of cancer 36 (1) (2017)
Yun Jung Choi, Sung-Ho Beck, Woon Yong Kang, Soyoung Yoo, Seong-Yoon Kim, Ji Sung Lee, Tal Burt, Tae Won Kim
Knowledge and Perception about Clinical Research Shapes Behavior: Face to Face Survey in Korean General Public. Journal of Korean medical science 31 (5) (2016)
Masahito Kotaka, Ruihua Xu, Kei Muro, Young Suk Park, Satoshi Morita, Satoru Iwasa, Hiroyuki Uetake, Tomohiro Nishina, Hiroaki Nozawa, Hiroshi Matsumoto, Kentaro Yamazaki, Sae-Won Han, Wei Wang, Joong Bae Ahn, Yanhong Deng, Sang-Hee Cho, Yi Ba, Keun-Wook Lee, Tao Zhang, Taroh Satoh, Marc E Buyse, Baek-Yeol Ryoo, Lin Shen, Junichi Sakamoto, Tae Won Kim
Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab. Chinese journal of cancer 35 (1) (2016)